Skip to content

Effects of Tai Chi Yunshou motor imagery training for hemiplagic upper extremity motor function in patients with stroke

Effects of contralateral Tai Chi Yunshou motor imagery training and contralateral motor imagery training for hemiplagic upper extremity motor function in patients with stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006622
Enrollment
Unknown
Registered
2022-09-19
Start date
2022-09-06
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

control group:contralateral motor imagery training and routine rehabilitation training
test group:contralateral Taiji Yunshou motor imagery training and routine rehabilitation training

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) First stroke and in accordance with the "Diagnostic Essentials of Various Major Cerebrovascular Diseases in China 2019", confirmed by CT or MRI as cerebral infarction or cerebral hemorrhage. (2) Any gender, 40 years old = age = 80 years old. (3) Time of onset 2 weeks - 6 months (stroke recovery). (4) Edinburgh Handedness Inventory (EHI) test for right handedness. (5) Presence of hemiplegic upper extremity and hand with Brunnstrom's hemiplegic functional rating of II-V. (6) Kinesthetic and visual imagery questionnaire (KVIQ-20) score = 25, with motor imagery ability. (7) Ability to cooperate with motor imagery training. (8) The subject or his/her legal guardian (if necessary) understands, voluntarily participates in this research trial, and signs the Informed Consent Form.

Exclusion criteria

Exclusion criteria: (1) Serious speech, attention, hearing, vision, intelligence, spirit or cognitive impairment (MMSE = 26 points); (2) Complicated with serious primary or secondary diseases, such as serious liver and kidney hematopoietic system diseases, severe cardiopulmonary insufficiency, arrhythmia, etc; (3) Patients who are participating in other clinical trial studies; (4) Unable to cooperate with the complete training and assessment for any reason.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment of Upper Extremity, FMA-UE;

Secondary

MeasureTime frame
pinch;Modified Ashworth Scale, MAS;grip;Brunnstrom rating scale;Functional Test of the Hemiparetic Upper Extremity-Hong Kong,FTHUE-HK;Modified Barthel Index, MBI;

Countries

China

Contacts

Public ContactQiRui
qirui@shyueyanghospital.com18930566807

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026